Assay News and Research

RSS

Sequenom announces Certified Service Provider program for technical certification

Sequenom, Inc., a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced a Certified Service Provider (CSP) program for the technical certification of selected laboratories offering research services using the Sequenom research-use-only MassARRAY System.

18 Sep 2013

Florida Hospital and VTT of Finland collaborate to predict early onsets of Alzheimer's disease

In an effort to better understand the development of Alzheimer's disease, Florida Hospital Neuroscience Institute and VTT Technical Research Centre of Finland are collaborating to identify the biomarker assay that may predict early onsets of the disease.

18 Sep 2013

Diagnoplex SA sign agreement with Unilabs to commercialize Colox colorectal cancer assay

Diagnoplex SA, a developer of molecular diagnostics for colorectal cancer and Unilabs, a leading supplier of clinical laboratory and medical diagnostic imaging services in Europe, signed a collaboration agreement to commercialize Colox, a minimally invasive colorectal cancer assay within the Unilabs network. The test will be available initially in the Swiss and Swedish markets.

18 Sep 2013

Scientists develop sophisticated assay to track cell growth at low nutrient concentrations

The budding yeast, Saccharomyces cerevisiae, is a prime organism for studying fundamental cellular processes, with the functions of many proteins important in the cell cycle and signaling networks found in human biology having first been discovered in yeast.

18 Sep 2013

Innovative platform improves diagnostics and detection of biomolecules

Separating target molecules in biological samples is a critical part of diagnosing and detecting diseases. Usually the target and probe molecules are mixed and then separated in batch processes that require multiple pipetting, tube washing and extraction steps that can affect accuracy.

18 Sep 2013

Video demonstrates high throughput screening of cellular bioenergetics of multiple cell lines

INTEGRA has published a video demonstrating how its VIAFLO 96 handheld electronic pipette, used in conjunction with the Seahorse Bioscience XF96 Extracellular Flux Analyzer, provides high throughput screening of the cellular bioenergetics of multiple cell lines.

From INTEGRA Biosciences 17 Sep 2013

Current criteria for ALK positive lung cancer needs to be redefined

A University of Colorado Cancer Center study published today in the journal Cancer shows that the current criteria used to match lung cancers with the drug crizotinib may miss some patients who could benefit from the drug. The findings suggest that doctors should look closer at borderline or atypical ALK-negative cases, and could widen the population of lung cancer patients offered treatment with crizotinib or other ALK-inhibitor drugs.

12 Sep 2013

Scientists develop novel, rapid way to test artemisinin-resistant malaria

For the first time, scientists have developed a novel and rapid way to test whether the most common and lethal form of malaria is resistant to potent artemisinin drugs.

12 Sep 2013

BioTek's new MultiFlo FX Microplate Dispenser combines dispensing and washing in one platform

BioTek's new MultiFlo FX Microplate Dispenser offers up to four independent reagent dispensers and a washer in one compact and modular platform to simplify and automate microplate-based liquid handling processes, thus saving time and reducing reagent costs.

12 Sep 2013

Ventana gets CFDA approval for VENTANA ALK immunohistochemistry assay

Ventana Medical Systems, Inc., a member of the Roche Group, today announced the approval of the VENTANA ALK immunohistochemistry assay by the Chinese Food and Drug Administration as a companion diagnostic to aid in the identification of patients for Pfizer's CFDA-approved oncology product XALKORI (crizotinib).

12 Sep 2013

Three rapid diagnostic tests could be used to diagnose drug resistance in TB

Results of a new study suggest that three new diagnostic tests could each be used to successfully diagnose drug resistance in tuberculosis (TB) patients in a quarter of the time taken by the current method.

10 Sep 2013

Nuclea Biotechnologies Acquires Wilex' U.S. Subsidiary

...

9 Sep 2013

Pharmathene presents new data from SparVax anthrax vaccine program at 2013 Bacillus conference

PharmAthene, Inc. announced today that new data from the Company's SparVax® next-generation anthrax vaccine program were presented in two separate oral presentations at the 2013 Bacillus – ACT international anthrax conference in Victoria, British Columbia, Canada.

7 Sep 2013

Study reveals hydrolyzed collagen may be suitable for nerve cell culture media

In the central nervous system, nerve cells adhere to the extracellular matrix. Type I collagen is the major class of insoluble fibrous proteins in the extracellular matrix. A previous study has shown that neural stem and progenitor cells, cultured on collagen matrices, are able to expand actively and generate neurons.

7 Sep 2013

Assay aids ALK fusion detection in lung adenonocarcinoma

A fully automated immunochemistry assay is highly sensitive and specific for detecting anaplastic lymphoma kinase fusion in primary lung adenocarcinomas, Chinese researchers report.

6 Sep 2013

Biomarker strategy in suspected ACS patients has potential to change clinical practice

An emergency department strategy that uses two biomarkers to triage patients with suspected acute coronary syndrome (ACS) can increase the rate of early, safe hospital discharge, according to results of the Biomarkers in Cardiology 8 (BIC-8) trial.

5 Sep 2013

Study identifies new tool to accurately analyze mtDNA deletions associated with diseases, aging

A study published today in Aging Cell identifies a new tool to accurately analyze extremely rare mitochondrial DNA deletions associated with a range of diseases and disorders as well as aging. This approach, which relies on Droplet Digital PCR (ddPCR-) technology, will help researchers explore mtDNA deletions as potential disease biomarkers.

4 Sep 2013

65 metabolites in urine simultaneously measured by clinical IEM-by-NMR screening study in Turkey

At the 12th International Congress of Inborn Errors of Metabolism (www.iciem2013.com), Bruker announces another milestone in the cost-effective use of NMR (nuclear magnetic resonance) spectroscopy screening as a clinical research tool for metabolic screening and small molecule in vitro diagnostics (IVD) research and validation.

4 Sep 2013

High sensitive troponin test may help doctors improve diagnosis in patients with heart attack

Abbott (NYSE: ABT) announced today promising preliminary results from a study presented at the ESC Congress 2013, suggesting that its high sensitive troponin test may help doctors improve the diagnosis and prognosis of patients presenting with symptoms of a heart attack.

4 Sep 2013

Large study shows effective test for diagnosis of C-Diff infection

The largest study of its kind has shown the most effective test for the diagnosis of Clostridium difficile (C-Diff), a bacterial infection which causes 15,000-20,000 deaths a year in hospitals in the United States.

4 Sep 2013

Assay News and Research

Sequenom announces Certified Service Provider program for technical certification

Florida Hospital and VTT of Finland collaborate to predict early onsets of Alzheimer's disease

Diagnoplex SA sign agreement with Unilabs to commercialize Colox colorectal cancer assay

Scientists develop sophisticated assay to track cell growth at low nutrient concentrations

Innovative platform improves diagnostics and detection of biomolecules

Video demonstrates high throughput screening of cellular bioenergetics of multiple cell lines

Current criteria for ALK positive lung cancer needs to be redefined

Scientists develop novel, rapid way to test artemisinin-resistant malaria

BioTek's new MultiFlo FX Microplate Dispenser combines dispensing and washing in one platform

Ventana gets CFDA approval for VENTANA ALK immunohistochemistry assay

Three rapid diagnostic tests could be used to diagnose drug resistance in TB

Nuclea Biotechnologies Acquires Wilex' U.S. Subsidiary

Pharmathene presents new data from SparVax anthrax vaccine program at 2013 Bacillus conference

Study reveals hydrolyzed collagen may be suitable for nerve cell culture media

Assay aids ALK fusion detection in lung adenonocarcinoma

Biomarker strategy in suspected ACS patients has potential to change clinical practice

Study identifies new tool to accurately analyze mtDNA deletions associated with diseases, aging

65 metabolites in urine simultaneously measured by clinical IEM-by-NMR screening study in Turkey

High sensitive troponin test may help doctors improve diagnosis in patients with heart attack

Large study shows effective test for diagnosis of C-Diff infection

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News